LIMD1 and lung carcinoma: Regarding lung cancer, in agreement with previous reports (4, 40), TCGA lung cancer cohort comprises high frequencies of Limd1 arm-level deletion correlating with somatic copy number alteration (sCNA), with LUSC (>75%) being higher than LUAD (~50%) (Figure 3B).